Page last updated: 2024-10-24

cefuroxime and Chronic Kidney Diseases

cefuroxime has been researched along with Chronic Kidney Diseases in 1 studies

Cefuroxime: Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
cefuroxime : A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.

Research Excerpts

ExcerptRelevanceReference
"Current dosing recommendations for cephalosporin antibiotics are on the basis of pharmacokinetic studies and are frequently ignored in practice."1.51Clinical Outcomes of Failing to Dose-Reduce Cephalosporin Antibiotics in Older Adults with CKD. ( Bathini, L; Battistella, M; Garg, AX; Jain, AK; Jandoc, R; Kuwornu, P; Liu, A; McArthur, E; Muanda, FT; Sood, MM; Weir, MA, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bathini, L1
Jandoc, R1
Kuwornu, P1
McArthur, E1
Weir, MA1
Sood, MM1
Battistella, M1
Muanda, FT1
Liu, A1
Jain, AK1
Garg, AX1

Other Studies

1 other study available for cefuroxime and Chronic Kidney Diseases

ArticleYear
Clinical Outcomes of Failing to Dose-Reduce Cephalosporin Antibiotics in Older Adults with CKD.
    Clinical journal of the American Society of Nephrology : CJASN, 2019, 02-07, Volume: 14, Issue:2

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefprozil; Cefuroxime; Cephalexin; Cephalosporins; D

2019